Tenderwize
Retour à la recherche

Pharmaceutical products

DAPSA·chanteau, France·Deadline Mar 21, 2030 · 1303 days left·Restricted·Supplies
Inscrivez-vous pour sauvegarder
Titre original de l'avis

France-Fleury-les-Aubrais: Pharmaceutical products

35/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

35 / 100

Complexité

40 / 100

Facteurs de risque

Critical details such as estimated value, eligibility criteria, and required documents are missing. The notice provides...

Structured data indicates a restricted procedure, while XML notice describes a dynamic purchasing system (DPS). This ma...

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 3 lots
  • Supply of pharmaceutical products (vaccines, medicines, and parapharmacy products) for operational use by the French Ministry of Defence.
  • The contract covers three distinct lots: vaccines, medicines, and parapharmacy products.
Afficher le résumé complet

This is a restricted procedure notice for the supply of pharmaceutical products (vaccines, medicines, and parapharmacy products) for operational purposes, issued by the French Ministry of Defence (ema/dcssa/daps-ssa). The notice was published on 2022-02-14, but the submission deadline is unusually far in the future (2030-03-21), likely indicating a dynamic purchasing system (DPS) despite structured data flags. Three lots are identified from the XML notice. No estimated value is provided. No procurement documents were analyzed beyond the notice itself.

Risques

Critical details such as estimated value, eligibility criteria, and required documents are missing. The notice provides...

Structured data indicates a restricted procedure, while XML notice describes a dynamic purchasing system (DPS). This ma...

Restricted procedure — pre-qualification required

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Procedure is restricted (structured data) but XML indicates a dynamic purchasing system (inconsistency noted).

Administrative

  • Submission is allowed for all lots (based on XML notice: 'TY TYPE BID: Submission for all lots').
  • Language: French (FRA) is required for submission.

Acheteur

Localisation

chanteau, FRA

Profil acheteur

Ouvrir le profil

Identifiant

15100002301258

Activité

Defence

Lots (3)

1

vaccins à visée opérationnelle

Supply of vaccines for operational purposes.

Catégorie

Pharmaceutical products

Date limite

Deadline Mar 21, 2030

2

médicaments à visée opérationnelle

Supply of medicines for operational purposes.

Catégorie

Pharmaceutical products

Date limite

Deadline Mar 21, 2030

3

produits de parapharmacie à visée opérationnelle

Supply of parapharmacy products for operational purposes.

Catégorie

Pharmaceutical products

Date limite

Deadline Mar 21, 2030

Détails de la procédure

Date de publication
14 Feb 2022
Langues
French

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
81444-2022

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3